Article Text

Download PDFPDF

1129 Downregulation of LIMA1expression induces cancer features in normal cervical keratinocyte HCK1T cells leading to increased migration and invasion
  1. E Drakopoulou1,
  2. E Kalafati1,
  3. AG Vasilopoulou1,
  4. N Anagnou1 and
  5. K Pappa1;2
  1. 1Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
  2. 2University of Athens, First Department of Obstetrics and Gynecology, Athens, Greece


Introduction/Background*Cervical cancer (CC) remains the fourth most common and lethal cancer type in women; therefore, a comprehensive understanding of the underlying mechanisms and development of novel diagnostic, prognostic and therapeutic approaches are critical steps for improving CC management. We have previously performed a detailed comparative proteomic analysis between HeLa, SiHa and CD33A CC cell lines and the normal cervical keratinocytes HCK1T cells (Pappa et al, Oncol Rep. 42:1441, 2019) aiming to elucidate novel and potential therapeutic targets. Among hundreds of deregulated proteins between cancer and normal cell lines, LIMA1 or EPLIN, a protein decreased or lost in neoplasia, was statistically downregulated in all CC cell lines. Since LIMA1 role in CC is not fully elucidated yet, we aimed to downregulate its expression in HCK1T cells and assess the putative induction of cancer characteristics, such as increased proliferation, migration and invasion. Additionally, we studied the global m6A RNA methylation pattern in the presence and absence of LIMA1, aiming to highlight a potential role of epitranscriptomics in cancer onset and progression.

Methodology We downregulated LIMA1 expression in the HCK1T cell line using a lentiviral vector (LV) carrying a shRNA for either LIMA1 (shLIMA1) or no target (shNT) at a multiplicity of infection (MOI) 25. Following LIMA1 quantification both at protein and mRNA level, we assessed proliferation, invasion, migration and colony formation efficiency in shNT or shLIMA1 LV-transduced HCK1T cells. Proliferation was assessed using CCK8, while invasion and migration using Transwell®, with or without matrigel-coated inserts, respectively. Qualitative and quantitative assessment of m6A RNA methylation was done by qPCR and colorimetric EpiQuick® kit respectively.

Result(s)*Transduction with shLIMA1 LV led to a 98% mean decrease of LIMA1 expression (n=3), leading to a 126% (p=0.021, n=3) and 103% (p=0.0091, n=3) increase in migration and invasion respectively, while we did not observe any difference in cell proliferation and colony formation efficiency. Preliminary data regarding m6A RNA methylation point towards a slight increase following LIMA1 knockdown.

Conclusion*LIMA1 may play an important role in cancer progression and metastasis and can set the grounds for novel and personalised therapy treatments for CC patients.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.